• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

    8/22/22 6:22:57 AM ET
    $ADGI
    $AEVA
    $AMZN
    $MNMD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $ADGI alert in real time by email
    • Signify Health, Inc. (NYSE:SGFY) rose 36.8% to $29.00 in pre-market trading after the Wall Street Journal reported that Amazon.com, Inc. (NASDAQ:AMZN) is among the potential bidders for the healthcare company, along with the previously reported CVS.
    • GigaCloud Technology Inc. (NASDAQ:GCT) rose 11% to $53.29 in pre-market trading after jumping 206% on Friday.
    • Adagio Therapeutics, Inc (NASDAQ:ADGI) rose 9.1% to $4.58 in pre-market trading after declining around 7% on Friday. Adagio Therapeutics recently posted a Q2 loss of $0.47 per share.
    • NaaS Technology Inc. (NASDAQ:NAAS) gained 8.1% to $7.11 in pre-market trading following Q2 results. Total gross revenues surged 47% year-over-year to RMB56.3 million (US$8.4 million) for the second quarter.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) rose 7.3% to $0.9090 in pre-market trading after dropping 17% on Friday.
    • Veru Inc. (NASDAQ:VERU) rose 7% to $18.70 in pre-market trading. Veru named Jason Davies as Executive Vice President – General Manager of Europe, the Middle East and Africa (EMEA), Latin America (LATAM), and Asia Pacific (APAC) for Veru’s Infectious Disease Franchise for Veru International.
    • Aeva Technologies, Inc. (NYSE:AEVA) gained 4.2% to $3.25 in pre-market trading after dropping 9% on Friday.

    Also check this out: Nasdaq Futures Down 200 Points Following Friday's Plunge; Crude Oil Drops .

    Get the next $ADGI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADGI
    $AEVA
    $AMZN
    $MNMD

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    3/25/2026$265.00 → $280.00Overweight
    Analyst
    Amazon.com Inc.
    $AMZN
    2/23/2026$305.00 → $304.00Overweight
    Wells Fargo
    Amazon.com Inc.
    $AMZN
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    Amazon.com Inc.
    $AMZN
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    Amazon.com Inc.
    $AMZN
    2/2/2026$300.00 → $315.00Mkt Outperform
    Citizens JMP
    Amazon.com Inc.
    $AMZN
    1/28/2026$305.00 → $315.00Outperform
    Oppenheimer
    Amazon.com Inc.
    $AMZN
    1/28/2026$303.00 → $308.00Overweight
    KeyBanc Capital Markets
    Amazon.com Inc.
    $AMZN
    1/27/2026$295.00 → $300.00Buy
    Stifel
    More analyst ratings

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rezk Mina

    4 - Aeva Technologies, Inc. (0001789029) (Issuer)

    3/19/26 8:30:03 PM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    SEC Form 3 filed by new insider Dai Zhen

    3 - NaaS Technology Inc. (0001712178) (Issuer)

    3/18/26 1:55:33 PM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Zhang Wei (Nmn)

    3 - NaaS Technology Inc. (0001712178) (Issuer)

    3/18/26 1:54:03 PM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst reiterated coverage on Amazon with a new price target

    Analyst reiterated coverage of Amazon with a rating of Overweight and set a new price target of $280.00 from $265.00 previously

    3/25/26 10:59:48 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Wells Fargo reiterated coverage on Amazon with a new price target

    Wells Fargo reiterated coverage of Amazon with a rating of Overweight and set a new price target of $304.00 from $305.00 previously

    2/23/26 10:45:11 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Monness Crespi & Hardt reiterated coverage on Amazon with a new price target

    Monness Crespi & Hardt reiterated coverage of Amazon with a rating of Buy and set a new price target of $280.00 from $300.00 previously

    2/6/26 8:23:18 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tradr Launches Leveraged ETFs on AMZN, AAOI, HL and IBM

    First-to-market funds include strategies on blue-chip stocks Amazon.com and IBM NEW YORK, March 24, 2026 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched four new leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver either two times the inverse (-200%) or two times long (200%) the daily performance of a specific underlying stock. All four ETFs are first-to-market strategies.The following ETFs are expected to open for trading today:Tradr 2X Short AMZN Daily ETF (Cboe: AMZO) – tracks Amazon.com Inc. (NASDAQ:AMZN)Tradr 2X Long AAOI Daily ETF (Cboe: AAOX) – tracks Applied Optoelectronics Inc. (NASDAQ:AA

    3/24/26 8:41:00 AM ET
    $AAOI
    $AMZN
    $HL
    Semiconductors
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary

    Tradr Set to Launch Leveraged ETFs on AMZN, AAOI, HL and IBM

    All four strategies represent first-to-market exposures on emerging growth and blue-chip stocksNEW YORK, March 23, 2026 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, announced that it expects to launch four first-to-market single stock leveraged ETFs on Tuesday, March 24. The Cboe-listed funds seek to deliver either two times the inverse (-200%) or two times long (200%) the daily performance of a specific underlying stock.Expected Tradr launches:Tradr 2X Short AMZN Daily ETF (Cboe: AMZO) – tracks Amazon.com Inc. (NASDAQ:AMZN)Tradr 2X Long AAOI Daily ETF (Cboe: AAOX) – tracks Applied Optoelectronics Inc. (NASDAQ:AAOI)Tradr 2X Lon

    3/23/26 10:42:00 AM ET
    $AAOI
    $AMZN
    $HL
    Semiconductors
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary

    Hammacher Schlemmer acquired by ex-Woot leadership team

    New stewards aim to restore company's status as America's innovation storeNEW YORK, March 19, 2026 /PRNewswire/ -- Stores.com announced today it has acquired Hammacher Schlemmer, aiming to reclaim the 178-year-old brand's mantle as the place for curious shoppers to discover "The Best, The Only, and The Unexpected". "Every Christmas season, there was one catalog I couldn't wait to get my hands on: Hammacher Schlemmer," says Matt Rutledge, CEO of Stores.com and founder and ex-CEO of Woot.com. "Now it just blows my mind that I've got the keys to the brand. And I can finally score o

    3/19/26 8:00:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Large owner Sylebra Capital Llc bought $23,284,844 worth of shares (3,559,227 units at $6.54) (SEC Form 4)

    4/A - Aeva Technologies, Inc. (0001789029) (Issuer)

    5/9/25 7:22:29 AM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    Large owner Sylebra Capital Llc bought $23,284,844 worth of shares (3,559,227 units at $6.54) (SEC Form 4)

    4 - Aeva Technologies, Inc. (0001789029) (Issuer)

    3/31/25 8:49:23 PM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    Large owner Sylebra Capital Llc bought $11,229,740 worth of shares (2,290,022 units at $4.90) (SEC Form 4)

    4 - Aeva Technologies, Inc. (0001789029) (Issuer)

    3/26/25 9:22:51 PM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Amazon.com Inc.

    SCHEDULE 13G/A - AMAZON COM INC (0001018724) (Subject)

    3/26/26 3:25:54 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form S-8 filed by Aeva Technologies Inc.

    S-8 - Aeva Technologies, Inc. (0001789029) (Filer)

    3/20/26 8:31:02 AM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    SEC Form 10-K filed by Aeva Technologies Inc.

    10-K - Aeva Technologies, Inc. (0001789029) (Filer)

    3/19/26 9:55:26 PM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by NaaS Technology Inc.

    SC 13G/A - NaaS Technology Inc. (0001712178) (Subject)

    11/14/24 9:58:25 PM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by NaaS Technology Inc.

    SC 13G/A - NaaS Technology Inc. (0001712178) (Subject)

    11/14/24 5:31:20 PM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Mind Medicine (MindMed) Inc.

    SC 13G/A - Mind Medicine (MindMed) Inc. (0001813814) (Subject)

    11/14/24 4:05:16 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    Leadership Updates

    Live Leadership Updates

    View All

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Hasbro Announces Additions to Board of Directors

    Doug Bowser and Carla Vernón to join as newest Board members Today, Hasbro, Inc. (NASDAQ:HAS), a leading games, IP and toy company, announced that Doug Bowser, retired President and Chief Operating Officer of Nintendo of America Inc., and Carla Vernón, Chief Executive Officer of The Honest Company, Inc. have been appointed to Hasbro's Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120899535/en/ "We are delighted to have Doug and Carla join our seasoned and dynamic Board of Directors," said Rich Stoddart, Chair of Hasbro's Board of Directors. "Doug and Carla bring extensive leadership experience across co

    1/20/26 8:30:00 AM ET
    $AMZN
    $GIS
    $HAS
    Catalog/Specialty Distribution
    Consumer Discretionary
    Packaged Foods
    Consumer Staples

    Morning Market Pulse: AI, Autonomy, and National Security Drive the Narrative at the Open

    DENVER, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Markets are waking up to a distinctly forward-looking tape, with investors parsing developments that point to shifts in Artificial Intelligence infrastructure, advanced sensing, defense-aligned energy systems, and deep-tech R&D platforms. Envirotech Vehicles (NASDAQ:EVTV): Strategic Pivot Toward AI Infrastructure Envirotech Vehicles is in focus after announcing an amended and restated Letter of Intent to acquire AZIO AI Corporation, a move that could dramatically reshape the company's long-term identity. The proposed all-equity transaction values AZIO AI at an assumed enterprise value of $480 million, using a $3.00 per share reference price for E

    1/6/26 9:52:32 AM ET
    $AEVA
    $EVTV
    $OPTT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Electric Utilities: Central
    Utilities

    $ADGI
    $AEVA
    $AMZN
    $MNMD
    Financials

    Live finance-specific insights

    View All

    Aeva Reports Fourth Quarter and Full Year 2025 Results

    Awarded Major Global Production Contract from Top 10 Passenger OEM Selected by Top 5 Passenger OEM for Global Vehicle Development Program Nvidia Selected Aeva as Reference LiDAR Sensor for DRIVE Hyperion Platform Doubled Revenue in 2025 Driven by Scaling Volume and New Markets Expansion Aeva® (NASDAQ:AEVA), a leader in next-generation sensing and perception systems, today announced its fourth quarter and full year 2025 results. Key Company Highlights A top European passenger OEM awarded Aeva a major production contract as the exclusive Tier-1 LiDAR supplier for the OEM's global L3 production program outside of China with targeted SOP in 2028 New top 5 passenger OEM selected

    2/26/26 4:05:00 PM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aeva Announces Date for Fourth Quarter and Full Year 2025 Results and Conference Call

    Aeva® (NASDAQ:AEVA), a leader in next-generation sensing and perception systems, today announced it will report results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026. Aeva will host a conference call and webcast to discuss the fourth quarter and full year 2025 results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. Event: Aeva Technologies, Inc. Fourth Quarter and Full Year 2025 Results Call Date: Thursday, February 26, 2026 Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Join by webcast: investors.aeva.com An archive of the webcast will be available shortly after the call on our investor relations website inv

    2/9/26 7:00:00 AM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary